Signaturefd, LLC Blueprint Medicines Corp Transaction History
Signaturefd, LLC
- $4.94 Billion
- Q1 2025
A detailed history of Signaturefd, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Signaturefd, LLC holds 153 shares of BPMC stock, worth $19,522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153
Previous 180
15.0%
Holding current value
$19,522
Previous $15,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BPMC
# of Institutions
391Shares Held
68.5MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$848 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$847 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$691 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$491 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$392 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.62B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...